MALIA MCCOY: Open Payments
NPI 1861960361 · LEOMINSTER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$895 in 43 payments from 11 companies in 2025. Trend: 2023 $127 · 2024 $770 · 2025 $895
Food & beverage: $795Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $428 |
| Lilly USA, LLC | 8 | $118 |
| Janssen Biotech, Inc. | 1 | $100 |
| Galderma Laboratories, L.P. | 3 | $64 |
| GENZYME CORPORATION | 1 | $42 |
| UCB, Inc. | 2 | $40 |
| PFIZER INC. | 1 | $25 |
| Verrica Pharmaceuticals Inc. | 1 | $23 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
| Novartis Pharmaceuticals Corporation | 1 | $19 |
Products named: RINVOQ, SKYRIZI, TREMFYA, TALTZ, EBGLYSS, DUPIXENT, Bimzelx, NEMLUVIO.
Industry payments across MA — which companies pay providers there.
